Bax, a member of the Bcl-2 gene family, is known to promote apoptosis in many cases but to block cell death under certain conditions. To investigate the potential role of Bax in 6-hydroxydopamine (6-OHDA)-induced cell death, we first established and character- 
INTRODUCTION
Apoptosis is a strictly regulated process to remove unnecessary, aged, or damaged cells in various situations (35) . It is accompanied by several morphological features typified by cell shrinkage, membrane blebbing, and perinuclear chromatin condensation. The family of Bcl-2-related proteins has been extensively shown to regulate the apoptotic process (15, 19, 30, 31) . Interestingly, the Bcl-2 family proteins are functionally categorized into death-inhibiting or death-inducing members. For example, Bcl-2 and Bcl-X L are known to enhance cell survival by preventing apoptotic cell death induced by a wide variety of stimuli whereas Bax has been shown to promote apoptosis in many cell death paradigms of the mammalian system (29) .
There has been much speculation regarding the biochemical and molecular mechanism(s) utilized by Bcl-2-related proteins to determine the fate of a cell in response to various stresses (39) . Among them, it has been initially proposed that death-inhibiting proteins such as Bcl-2 and Bcl-X L heterodimerize with Bax to repress cell death (41) . Recently, it appears that many other members of the Bcl-2-related family also interact with each other to form a dynamic equilibrium between homo-and heterodimers, determining the cellular response to death stimuli (19, 31) . However, proapoptotic proteins such as Bax and Bak unexpectedly exhibit protective functions in some cellular contexts (18, 22, 26) . These results raise the possibility that the functional role of Bax may be far more complicated than the simple relationship between pro-and antiapoptotic proteins among Bcl-2-related proteins.
Unilateral lesions with the neurotoxin 6-hydroxydopamine (6-OHDA) in the area of mesencephalic dopaminergic neuronal cell bodies or their projecting fibers of rodents have provided an important model system to study dopaminergic neuronal cell death associated with Parkinson's disease (8) . Furthermore, 6-OHDA has been recently found to be formed endogenously in patients suffering Parkinson's disease (9) . Although the exact mechanism(s) underlying the cause of Parkinson's disease remains elusive, several studies using 6-OHDA have revealed possible biochemical pathways that give rise to dopaminergic neuronal cell death (9) . It has been suggested that 6-OHDA has two ways of action, primarily formation of free radicals and inhibition of mitochondrial respiratory chain complexes (I and IV). As a result, treatment with 6-OHDA induces apoptotic cell death in vivo as well as in vitro (20, 38) . These studies are consistent with the postulate that apoptosis is a major pathway of dopaminergic neuronal cell death in Parkinson's disease (23, 37) . Even though the expression level of Bcl-2-related proteins (Bax, Bcl-2, and Bcl-X L ) following 6-OHDA treatment has already been studied, a direct role of these proteins is yet to be established.
Thus, the specific aim of the present study is to directly investigate the role of Bcl-2-related proteins at the cellular level in 6-OHDA-induced dopaminergic neuronal cell death. To meet this end, we utilized a dopaminergic neuronal cell line, MN9D (4), in which we overexpressed hemagglutinin epitope-tagged Bax (MN9D/HA-Bax). We also utilized MN9D cell lines stably transfected with human bcl-2 (MN9D/Bcl-2) or bcl-X L (MN9D/Bcl-X L ). Cells from each clone were treated with 6-OHDA and the protective role of each protein was subsequently evaluated. Other prooxidants such as menadione and hydrogen peroxide were used for comparison.
MATERIALS AND METHODS
Establishment of HA-tagged Bax-expressing MN9D cell lines. MN9D cells plated at 2 ϫ 10 5 cells onto a poly-D-lysine coated six-well plate (Corning) were transfected with a eukaryotic expression vector, pcDNA3, containing hemagglutinin epitope-tagged bax cDNA sequences (a generous gift from Dr. J. C. Reed at the Burnham Institute; MN9D/HA-Bax) or pcDNA3 itself (MN9D/Neo) as described previously (27) . After transfection using lipofectamine (Gibco), G 418-resistant colonies were subsequently selected for 10 days and expanded in DMEM supplemented with 10% fetal bovine serum and 500 µg/ml G 418 (complete culture medium; CCM). Stable MN9D/HA-Bax clones were characterized by western blot analysis using monoclonal anti-HA antibody (Boehringer Mannheim). MN9D/ Bcl-2 and MN9D/Bcl-X L were previously established and used for the experiments (24, 27) .
Cell culture and MTT reduction assay. For experiments, cells from each established cell line were plated onto poly-D-lysine-coated plates at a density of 2 ϫ 10 4 /48-well plate (Corning) and cultivated in CCM for 3 days with an atmosphere of 10% CO 2 at 37°C. Cells were subsequently switched to serum-free N2 medium (3), treated with various experimental reagents, and further incubated for the indicated time periods. Reagents consisted of 6-OHDA (25-100 µM; RBI), menadione (10-50 µM; Sigma), and hydrogen peroxide (0.25-2.0 mM; Sigma). Following incubation with various experimental reagents, the rate of cell survival was assessed by colorimetric measurement of 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) reduction, which is an indicator of the pyridine nucleotide redox state of the cell, as described previously (11, 32) . Values from each treatment were expressed as a percentage of survival over the nontreated control (100% survival). Cells were examined under a Carl Zeiss Axiovert 100 Microscope equipped with a differential interference contrast filter. Phase-contrast photographs were made using Kodak Tmax 100.
Detection of DNA fragmentation pattern. Cells cultured on poly-D-lysine-coated P-100 dishes in CCM were treated with 100 µM 6-OHDA for various time periods, washed three times with ice-cold PBS, and lysed in a buffer containing 0.5% Triton X-100, 5 mM Tris, pH 7.4, and 20 mM EDTA for 30 min on ice as described previously (12) . Following microcentrifugation at 4°C for 15 min, supernatants containing soluble DNA were subjected to phenol/chloroform extraction and ethanol precipitation. Half of the resulting precipitates dissolved in 1ϫ TE was electrophoresed on 1.2% agarose gels. Gels were treated with 1 mg/ml DNasefree RNase (Boehringer Mannheim), stained with ethidium bromide, and visualized under a UV transilluminator.
Western blot analysis. For measuring the expression levels of HA-Bax and the cleavage pattern of poly(ADP-ribose)polymerase (PARP) in MN9D cells by Western blot analysis, cells (Ͼ5-20 ϫ 10 6 ) cultivated in poly-D-lysine-coated P-100 dishes (Corning) were washed with ice-cold PBS and lysed in a buffer containing 50 mM Tris, pH 7.0, 2 mM EDTA, 1% Triton X-100, 2 mM PMSF, 10 µg/ml leupeptin and aprotinin for 15 min. Lysates were centrifuged at 13,000g for 30 min at 4°C. The supernatants were transferred into new Eppendorf tubes and kept at Ϫ70°C until use. After measuring protein content using Bio-Rad protein assay reagent, 25-50 µg of protein from each sample was separated on 10-12.5% SDS-PAGE, blotted onto prewet PVDF-nitrocellulose filters, and processed for Western blot analysis using monoclonal anti-HA (1:1000; Boehringer Mannheim) or monoclonal anti-PARP antibody (1:5000; Enzyme Systems Products). Specific bands were detected by enhanced chemiluminescence (Amersham) as recommended by the manufacturer.
RESULTS
To establish MN9D stable cells constitutively overexpressing Bax, cells were transfected with either a pcDNA3 eukaryotic expression vector containing hemagglutinin epitope-tagged murine bax cDNA sequences (MN9D/HA-Bax) or pcDNA3 alone (MN9D/Neo). Ten separately derived MN9D/HA-Bax clones were picked, expanded in CCM, and characterized by Western blot analysis using monoclonal anti-HA antibody. As shown in Fig. 1 Exposure of MN9D/Neo as well as MN9D parent cells to a neurotoxin, 6-OHDA, resulted in a concentrationand time-dependent cell death (100 µM 6-OHDA for 18-20 h for maximum effect). To investigate the potential role of Bax in an experimental model of dopaminergic neuronal cell death, both MN9D/Neo and MN9D/HABax cells were treated with 100 µM 6-OHDA for 18-20 h. In MN9D/Neo cells, treatment of 6-OHDA induced several morphological changes including shrinkage of the cytoplasmic membrane, condensation of nuclei, generation of apoptotic bodies, and retraction of neurites ( Fig. 2A) . Similar results were obtained in a wide range of concentrations of 6-OHDA even though lower concentrations took longer to induce these changes. However, these morphological changes were largely undetectable in 6-OHDA-treated MN9D/HA-Bax cells (Fig. 2B ). The nuclear area was translucent and the nucleoli were still prominent under this condition. When the survival rate of MN9D/Neo and MN9D/HABax following treatment with 100 µM 6-OHDA for 18-20 h was quantitated by the MTT reduction assay, only 23.6% of MN9D/Neo cells survived while far more cells from MN9D/HA-Bax clones 3, 4, and 8 were alive (70.1, 65.3, and 56.2%, respectively; Fig. 3 ). Interestingly, overexpression of either Bcl-2 or Bcl-X L , a wellknown antiapoptotic protein, did not rescue 6-OHDAinduced cell death, suggesting that overexpression of HA-Bax but not Bcl-2 or Bcl-X L attenuates 6-OHDAinduced neuronal apoptotic cell death. In a preliminary study, all three MN9D/HA-Bax clones did not block cell death induced by another dopaminergic neurotoxin, MPP ϩ (100 µM for 40-44 h; 17.8% survival for MN9D/ Neo vs 16.4-21.7% survival for three MN9D/HA-Bax clones).
In our previous study, we have demonstrated that 6-OHDA induces the generation of internucleosomal DNA fragmentation in MN9D cells (24) . To determine whether overexpression of HA-Bax attenuates this phenomenon, both MN9D/Neo and MN9D/HA-Bax clone 3 cells were treated with 100 µM 6-OHDA for the indicated time periods. Triton X-100-soluble DNA from each group was harvested and analyzed on a 1.2% agarose gel. Although the generation of DNA fragmentation pattern was observed in both MN9D/Neo and MN9D/HA-Bax cells starting from 12 h after 6-OHDA treatment, it was largely attenuated in MN9D/HA-Bax cells (Fig. 4A) . Cascade activation of caspases is shown to trigger apoptosis, resulting in cleavage of several substrates including PARP (21) . Therefore, we investigated whether the protective role of HA-Bax is mediated by blocking caspase activation following 6-OHDA treatment. As shown Fig. 4B , cleavage of PARP to 85 kDa by an activated caspase following 6-OHDA treatment was greatly attenuated in MN9D/HA-Bax cells compared with that in MN9D/Neo cells.
One of possible mechanisms by which 6-OHDA induces cell death has been ascribed to its known prooxidant role (28) . To investigate whether overexpression of HA-Bax attenuates other prooxidant-induced types of cell death, both MN9D/Neo and MN9D/HA-Bax cells (clone 3) were treated with 0.25-2.0 mM hydrogen peroxide or 10-50 µM menadione (a quinone that generates intracellular O 2 иϪ and H 2 O 2 , through a redox cycling process; 5, 36). As shown in Fig. 5A , overexpression of HA-Bax did not affect the cell death kinetics induced by menadione at all concentration ranges tested. However, hydrogen peroxide-induced cell death was greatly accelerated in MN9D/HA-Bax (Fig. 5B) . At 0.5 mM hydrogen peroxide, only 20.1% MN9D/HA-Bax cells survived while 73.3% of MN9D/Neo cells were still alive. The difference in the rate of cell survival between these cells was diminished at higher concentrations of hydrogen peroxide.
DISCUSSION
The proapoptotic Bcl-2 family members, including Bax and Bak, have also recently been shown to protect against cell death in particular types of cell injury (17, 18, 22, 26) . In the present study, we provide a further example of the protective role of Bax by demonstrating that overexpression of HA-Bax in a dopaminergic neuronal cell line (MN9D) greatly attenuates 6-OHDAinduced apoptosis possibly by inhibiting a caspasemediated cell death pathway. Interestingly, overexpression of HA-Bax does not affect the cell death kinetics induced by menadione at all concentrations tested. However, hydrogen peroxide-induced cell death was greatly accelerated in MN9D cells overexpressing HA-Bax, further strengthening the notion that the diverse roles of Bax may be determined by the type of stress applied to the system (26) . Under all of these experimental stresses, overexpression of a well-known antiapoptotic protein, Bcl-2 or Bcl-X L , does not affect the cell death kinetics (24) .
Previous studies indicate that production of reactive oxygen species (ROS) serves as an early signal to mediate apoptosis in neuronal cell types (10) . A central role for ROS in the pathogenesis of various types of neurodegenerative diseases has been widely accepted (1, 28) . In our system, we have observed that 6-OHDAinduced apoptotic cell death is largely attenuated in the presence of an antioxidant such as desferrioxamine, vitamine E, N-acetylcysteine, or superoxide dismutase, indicating that the death signaling pathway is triggered by oxidative stress (25) . In a variety of systems, overexpression of Bcl-2 or Bcl-X L has been shown to have antioxidant properties, delaying apoptosis by decreasing the net cellular generation of ROS and/or preventing toxic effects of ROS (2, 6, 7, 13, 16) . However, 6-OHDA-induced apoptotic death in MN9D cells is not blocked by overexpression of either Bcl-2 or Bcl-X L . This is consistent with previous reports demonstrating that Bcl-2 or Bcl-X L exerts an anti-cell death function by a mechanism other than regulation of ROS activity (14, 33) .
Administration of 1-methtyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 6-OHDA to nonhuman primates and other animal species causes selective destruction of the nigrostriatal pathway similar to that observed in Parkinson's disease. Although the exact mechanism(s) utilized by these dopaminergic neurotoxins is not known, MPTP (or its active metabolite, MPP ϩ ) causes cell death primarily by inhibiting mitochondrial respiratory chain complexes while 6-OHDA primarily forms ROS resulting in cell death (9, 34) . In our system, MPP ϩ -induced death in MN9D cells is greatly attenuated by overexpression of Bcl-2 or Bcl-X L but not by HA-Bax (24, 25) . This is quite contrary to the present findings that overexpression of HA-Bax but not Bcl-2 and Bcl-X L can attenuate 6-OHDA-induced cell death, raising the possibility that these neurotoxins trigger cell death by recruiting two distinct cell death pathways. Currently, we are carrying out extensive investigation to morphologically and biochemically distinguish these two cell deaths.
The mechanism(s) underlying how overexpression of Bax in MN9D cells attenuates 6-OHDA-induced cell death remains elusive. Considering our finding that Bax does not affect menadione-induced cell death and moreover accelerates hydrogen peroxide-induced cell death, it seems unlikely that Bax acts simply by shifting the cellular redox potential to a more reduced state and/or by affecting the major cellular antioxidant enzymes such as glutathione peroxidase, glutathione reductase, superoxide dismutase, and catalase. Our preliminary finding that the intracellular level of ROS measured by fluorescent dyes, 2Ј,7Ј-dichlorofluorescein diacetate and dihydroethidium, is quite similar in both MN9D/Neo and MN9D/HA-Bax following 6-OHDA treatment supports this notion. Rather, Bax could modify the response of cells by functioning downstream of ROS-mediated signaling. Another possibility could be that Bax attenuates 6-OHDA-induced cell death pathway that is quite apart from the known prooxidant activity of 6-OHDA.
Important questions remain as to how the anti-or proapoptotic function of Bax is determined in MN9D cells. Unlike what was previously reported for Jurkat cells (40) , overexpression of Bax itself in MN9D cells does not cause cell death, indicating that Bax alone is not sufficient to trigger cell death in MN9D cells. Although it is highly speculative at present, one plausible possibility in our system, therefore, could be that Bax may bind to a distinct partner protein or associate with a distinct cell death pathway activated under different stresses. The net outcome of this specific interaction may determine the role of Bax as a negative or positive modulator of cell death. Extensive studies regarding the action mechanism(s) will widen our knowledge of Bcl-2-related proteins in dopaminergic neuronal cell death and eventually lead to a better understanding of the pathogenesis of Parkinson's disease.
